Evidence map›Paper›PMID 26982446›Full record

Trial reportTelemedicine journal and e-health : the official journal of the American Telemedicine Association2016

Adult Cancer Patient Recruitment and Enrollment into Cell Phone Text Message Trials.

Sandra L Spoelstra, Alla Sikorskii, Charles W Given, Constantinos K Coursaris, Atreyee Majumder, Monica Schueller, Barbara A Given

Open access · greenAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Telemedicine journal and e-health : the official journal of the American Telemedicine Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Benchmarking Patient Recruitment and Retention Practices.Therapeutic innovation & regulatory science · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sandra L Spoelstra1 Kirkhof College of Nursing, Grand Valley State University , Grand Rapids, Michigan.
Alla Sikorskii2 Department of Statistics and Probability, Michigan State University , East Lansing, Michigan.
Charles W Given3 Department of Family Medicine, Michigan State University , East Lansing, Michigan.
Constantinos K Coursaris4 Department of Telecommunication, Information Studies, Michigan State University , East Lansing, Michigan.
Atreyee Majumder2 Department of Statistics and Probability, Michigan State University , East Lansing, Michigan.
Monica Schueller1 Kirkhof College of Nursing, Grand Valley State University , Grand Rapids, Michigan.
Barbara A Given5 College of Nursing, Michigan State University , East Lansing, Michigan.
Michigan State University · USGrand Valley State University · US

Funding

Text Messaging to Improve Adherence to Oral Chemotherapy AgentsR15CA176595 · NCI · MICHIGAN STATE UNIVERSITY · PI SPOELSTRA, SANDRA LEE · 2013 to 2013
$465k
NCI NIH HHS R15 CA176595
6 · The paper itself

Abstract

introductionText messaging (TMs) on cell phones is emerging as an effective means of delivering behavioral interventions. However, little is known about TM use in adult cancer patients. The present study aimed to extend knowledge on acceptability of a TM intervention in adult cancer patients; examine factors of those screened and enrolled; and compare recruitment at a large national specialty pharmacy versus community-based cancer clinics. MATERIALS AND

methodsScreening, enrollment, and baseline data collected in two randomized controlled trials examining the efficacy of TMs on medication adherence or symptom severity in adults prescribed oral anticancer agents were linked. Chi-square, Fisher's exact, t-tests, and generalized linear modeling were used to examine sociodemographics, cancer type and stage, depressive symptoms, self-efficacy, social support, and symptoms.

resultsThe cancer clinics screened 293 patients, 43% were eligible, and 56% consented. The specialty pharmacy screened 169 patients, 72% were eligible, and 74% consented. Mean age was 58 years and did not differ by recruitment setting. Later stage disease (p = 0.01) and higher number of symptoms (p < 0.01), and symptom severity (p = 0.02) and interference (p = 0.01) were observed among patients recruited at the specialty pharmacy. No group differences were found for depression, physical function, cognition, self-efficacy, or social support. DISCUSSION: Adult cancer patients were likely to participate in a TM intervention trial. Recruiting through the specialty pharmacy reached a population with higher cell phone ownership and TM usage; with greater interest in a TM intervention compared to the cancer clinics.

Indexed as

Health StatusAdultAgedAntineoplastic AgentsCancer Care FacilitiesCell PhoneCommunity Pharmacy ServicesDepressionFemaleHumansMaleMedication AdherenceMiddle AgedNeoplasmsNeoplasm StagingPatient SatisfactionAntineoplastic Agentscancerm-healthoncologyrandomized controlled trialrecruitmenttext messaging

Identifiers

PMID26982446
PMCPMC5087987
OpenAlexW2302965392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.